Roivant Sciences Ltd. (ROIV)
CIK 1635088 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Roivant Sciences Ltd..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 10, 2026 | 4 | 0001140361-26-036246 |
| Sep 8, 2026 | 144 | 0001950047-26-009199 |
| Sep 8, 2026 | 8-K | 0001140361-26-035859 |
| Sep 1, 2026 | 4 | 0001140361-26-035375 |
| Aug 28, 2026 | 144 | 0001965301-26-000133 |
| Aug 28, 2026 | 8-K | 0001140361-26-034854 |
| Aug 27, 2026 | 8-K | 0001140361-26-034735 |
| Aug 24, 2026 | 4 | 0001140361-26-034238 |
| Aug 24, 2026 | 4 | 0001140361-26-034239 |
| Aug 21, 2026 | 4 | 0001140361-26-034066 |
| Aug 21, 2026 | 144 | 0001950047-26-008512 |
| Aug 20, 2026 | 144 | 0001950047-26-008467 |
| Aug 19, 2026 | 144 | 0001950047-26-008392 |
| Aug 18, 2026 | 4 | 0001140361-26-033637 |
| Aug 18, 2026 | 144 | 0001950047-26-008341 |
| Aug 17, 2026 | 144 | 0001950047-26-008265 |
| Aug 14, 2026 | 144 | 0001950047-26-008125 |
| Aug 13, 2026 | SCHEDULE 13G/A | 0000895421-26-000250 |
| Aug 6, 2026 | 10-Q | 0001635088-26-000090 |
| Aug 6, 2026 | 8-K | 0001635088-26-000088 |
| Jul 29, 2026 | 4 | 0001140361-26-030107 |
| Jul 29, 2026 | DEF 14A | 0001140361-26-029955 |
| Jul 29, 2026 | DEFA14A | 0001140361-26-029956 |
| Jul 29, 2026 | ARS | 0001140361-26-029957 |
| Jul 27, 2026 | 144 | 0001965301-26-000094 |